{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T18:08:17Z","timestamp":1788286097376,"version":"build-2803163510"},"reference-count":40,"publisher":"Impact Journals, LLC","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,3,21]]},"DOI":"10.18632\/oncotarget.9409","type":"journal-article","created":{"date-parts":[[2016,5,23]],"date-time":"2016-05-23T19:06:01Z","timestamp":1464030361000},"page":"18712-18725","source":"Crossref","is-referenced-by-count":53,"title":["Up-regulation of SERPINA3 correlates with high mortality of melanoma patients and increased migration and invasion of cancer cells"],"prefix":"10.18632","volume":"8","author":[{"given":"Jiaying","family":"Zhou","sequence":"first","affiliation":[{"name":"Faculty of Science, University of British Columbia, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yabin","family":"Cheng","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Xiamen University, Xiamen, China"},{"name":"Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liren","family":"Tang","sequence":"additional","affiliation":[{"name":"Welichem Biotech Inc, Burnaby, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Martinka","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Kalia","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,5,17]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1200\/JCO.2007.13.8123","article-title":"Predicting outcomes in metastatic melanoma","volume":"26","author":"Soong","year":"2008","journal-title":"J Clin Oncol"},{"key":"2","first-page":"71","article-title":"Understanding the trends in melanoma incidence and mortality: where do we stand?","volume":"10","author":"Naeyaert","year":"2000","journal-title":"Eur J Dermatol"},{"key":"3","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(13)60802-8","article-title":"Cutaneous melanoma","volume":"383","author":"Robert","year":"2014","journal-title":"Lancet"},{"key":"4","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/ng1296-457","article-title":"Use of a cDNA microarray to analyse gene expression patterns in human cancer","volume":"14","author":"Trent","year":"1996","journal-title":"Nat Genet"},{"key":"5","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1177\/107327480801500303","article-title":"The impact of genomics in understanding human melanoma progression and metastasis","volume":"15","author":"Riker","year":"2008","journal-title":"Cancer Control"},{"key":"6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1755-8794-1-13","article-title":"The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis","volume":"1","author":"Matta","year":"2008","journal-title":"BMC Med Genomics"},{"key":"7","first-page":"1966","article-title":"Tissue microarrays for gene amplification surveys in many different tumor types","volume":"5","author":"Sauter","year":"1999","journal-title":"Clin Cancer Res"},{"key":"8","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/jnci\/djj103","article-title":"Gene expression profiling of primary cutaneous melanoma and clinical outcome","volume":"98","author":"Spatz","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"9","doi-asserted-by":"publisher","first-page":"4180","DOI":"10.18632\/oncotarget.2907","article-title":"Stage-specific prognostic biomarkers in melanoma","volume":"6","author":"Zhou","year":"2015","journal-title":"Oncotarget"},{"key":"10","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1158\/1078-0432.CCR-06-0030","article-title":"Aberrant expression of collagen triple helix repeat containing 1 in human solid cancers","volume":"12","author":"Zhou","year":"2006","journal-title":"Clin Cancer Res"},{"key":"11","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/j.0022-202X.2005.23680.x","article-title":"Osteopontin expression correlates with melanoma invasion","volume":"124","author":"Li","year":"2005","journal-title":"The Journal of investigative dermatology"},{"key":"12","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00000478-198702000-00007","article-title":"Anti-alpha 1-antichymotrypsin staining of 194 sarcomas, 38 carcinomas, and 17 malignant melanomas. Its lack of specificity as a tumour marker","volume":"11","author":"Henry","year":"1987","journal-title":"Am J Surg Pathol"},{"key":"13","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1755-148X.2010.00715.x","article-title":"Alpha 1 antichymotrypsin is aberrantly expressed during melanoma progression and predicts poor survival for patients with metastatic melanoma","volume":"23","author":"Zhou","year":"2010","journal-title":"Pigment cell & melanoma research"},{"key":"14","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/1357-2725(96)00032-5","article-title":"Alpha 1-antichymotrypsin","volume":"28","author":"Kalsheker","year":"1996","journal-title":"The international journal of biochemistry & cell biology"},{"key":"15","first-page":"1359","article-title":"Plasma proteinase inhibitors","volume":"114","author":"Schnebli","year":"1984","journal-title":"Schweiz Med Wochenschr"},{"key":"16","doi-asserted-by":"crossref","first-page":"5055","DOI":"10.1021\/bi00291a001","article-title":"Sequence homology between human alpha 1-antichymotrypsin, alpha 1-antitrypsin, and antithrombin III","volume":"22","author":"Woo","year":"1983","journal-title":"Biochemistry"},{"key":"17","first-page":"116","article-title":"[Characterization of alpha-1-X-glycoprotein as chymotrypsin inhibitor of human plasma]","volume":"12","author":"Haupt","year":"1965","journal-title":"Clin Chim Acta"},{"key":"18","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/ijc.2910450207","article-title":"Prognostic significance of alpha-1-antitrypsin in early stage of colorectal carcinomas","volume":"45","author":"Koono","year":"1990","journal-title":"Int J Cancer"},{"key":"19","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/ajcp\/95.6.835","article-title":"Prognostic value of serum proteins synthesized by breast carcinoma cells","volume":"95","author":"van Melle","year":"1991","journal-title":"Am J Clin Pathol"},{"key":"20","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1432-0436.2005.07302001.x","article-title":"Tumor-host interactions contribute to the elevated expression level of alpha1-antichymotrypsin in metastatic breast tumor xenografts","volume":"73","author":"Tarin","year":"2005","journal-title":"Differentiation"},{"key":"21","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1349-7006.2004.tb02198.x","article-title":"mRNA expression level of estrogen-inducible gene, alpha 1-antichymotrypsin, is a predictor of early tumor recurrence in patients with invasive breast cancers","volume":"95","author":"Noguchi","year":"2004","journal-title":"Cancer Sci"},{"key":"22","first-page":"313","article-title":"[Molecular forms of prostate-specific antigen and human kallikrein 2 as possible indicators in prostatic carcinoma diagnosis]","volume":"39","author":"Loening","year":"2000","journal-title":"Urologe A"},{"key":"23","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0090-4295(01)01449-2","article-title":"Prostate-specific antigen, its molecular forms, and other kallikrein markers for detection of prostate cancer","volume":"59","author":"Loening","year":"2002","journal-title":"Urology"},{"key":"24","first-page":"1133","article-title":"Molecular forms of prostate-specific antigen and human kallikrein 2 as promising tools for early diagnosis of prostate cancer","volume":"9","author":"Loening","year":"2000","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"25","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1016\/j.ejca.2007.06.006","article-title":"PSA and other tissue kallikreins for prostate cancer detection","volume":"43","author":"Diamandis","year":"2007","journal-title":"Eur J Cancer"},{"key":"26","first-page":"111","article-title":"Serum alpha-1-antitrypsin and alpha-1-antichymotrypsin after surgical treatment and during postoperative clinical course of human gastric cancer","volume":"40","author":"Klimiuk","year":"1993","journal-title":"Neoplasma"},{"key":"27","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/1097-0142(19951015)76:8<1368::AID-CNCR2820760812>3.0.CO;2-N","article-title":"Alpha-1-antichymotrypsin expression in lung adenocarcinoma and its possible association with tumor progression","volume":"76","author":"Tateishi","year":"1995","journal-title":"Cancer"},{"key":"28","first-page":"321","article-title":"Incorporation of alpha-1-antichymotrypsin into human stomach adenocarcinoma cell nuclei and inhibition of DNA primase activity","volume":"13","author":"Katsunuma","year":"1988","journal-title":"Tokai J Exp Clin Med"},{"key":"29","first-page":"241","article-title":"Increased plasma levels of serine proteinase inhibitors in lung cancer patients","volume":"24","author":"Janciauskiene","year":"2004","journal-title":"Anticancer Res"},{"key":"30","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0046-8177(84)80125-2","article-title":"Alpha 1-antitrypsin, alpha 1-antichymotrypsin, and alpha 2-macroglobulin in human gastric carcinomas: a retrospective immunohistochemical study","volume":"15","author":"Hata","year":"1984","journal-title":"Human pathology"},{"key":"31","first-page":"1348","article-title":"SERPINA3 promotes endometrial cancer cells growth by regulating G2\/M cell cycle checkpoint and apoptosis","volume":"7","author":"Zhang","year":"2014","journal-title":"International journal of clinical and experimental pathology"},{"key":"32","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0065-230X(08)60028-7","article-title":"Plasminogen activators, tissue degradation, and cancer","volume":"44","author":"Skriver","year":"1985","journal-title":"Adv Cancer Res"},{"key":"33","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1152\/physrev.1993.73.1.161","article-title":"Biology and biochemistry of proteinases in tumor invasion","volume":"73","author":"Rifkin","year":"1993","journal-title":"Physiol Rev"},{"key":"34","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1177\/014107689308601010","article-title":"Proteinase inhibitors in malignancy: therapeutic promise or another white elephant?","volume":"86","author":"Dodwell","year":"1993","journal-title":"J R Soc Med"},{"key":"35","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/35077241","article-title":"The microenvironment of the tumour-host interface","volume":"411","author":"Kohn","year":"2001","journal-title":"Nature"},{"key":"36","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.1440-1827.2002.01320.x","article-title":"Emerging multifunctional aspects of cellular serine proteinase inhibitors in tumor progression and tissue regeneration","volume":"52","author":"Koono","year":"2002","journal-title":"Pathol Int"},{"key":"37","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/modpathol.2013.223","article-title":"DLC1 expression is reduced in human cutaneous melanoma and correlates with patient survival","volume":"27","author":"Li","year":"2014","journal-title":"Modern pathology"},{"key":"38","first-page":"138","article-title":"[Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]","volume":"8","author":"Stegner","year":"1987","journal-title":"Der Pathologe"},{"key":"39","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.imlet.2008.03.017","article-title":"The plasminogen activator inhibitor \u201cparadox\u201d in cancer","volume":"118","author":"Mihaly","year":"2008","journal-title":"Immunol Lett"},{"key":"40","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/carcin\/bgt346","article-title":"Prognostic significance of KAI1\/CD82 in human melanoma and its role in cell migration and invasion through the regulation of ING4","volume":"35","author":"Li","year":"2014","journal-title":"Carcinogenesis"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.9409","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T15:14:55Z","timestamp":1692371695000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.9409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,17]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,3,21]]}},"alternative-id":["9409","27213583"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.9409","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,17]]}}}